Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPID | Q08752 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.56 |
| ▸ | NAMPT | P43490 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.56 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL8878788 | 1.00 | PPID (0.64) | PPIDSMN1; SMN2TSHRMAPTALOX15 | |
| Methacrylic Acid SCHEMBL26097617 | 0.91 | PPID (0.55) | PPIDSMN1; SMN2TSHRMAPTALOX15 | |
| SCHEMBL10599026 | 0.90 | TSHR (0.70) | PPIDSMN1; SMN2TSHRMAPTALOX15 | |
| SCHEMBL7788580 | 0.87 | TSHR (0.67) | PPIDSMN1; SMN2TSHRALOX15GAA | |
| SCHEMBL17342601 | 0.87 | TSHR (0.55) | PPIDSMN1; SMN2TSHRMAPTALOX15 | |
| SCHEMBL28540163 | 0.86 | TSHR (0.61) | PPIDSMN1; SMN2TSHRMAPTALOX15 | |
| SCHEMBL7422332 | 0.86 | HDAC1 (0.55) | PPIDMAPTHDAC1LMNAALDH1A1 | |
| SCHEMBL9136581 | 0.85 | LMNA (0.69) | SMN1; SMN2TSHRALOX15GAALMNA | |
| SCHEMBL5705124 | 0.85 | SMN1; SMN2 (0.64) | PPIDSMN1; SMN2TSHRMAPTALOX15 | |
| SCHEMBL29194212 | 0.84 | NPC1 (0.52) | PPIDSMN1; SMN2TSHRMAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110734073-B | Preparation method of gel factor attapulgite assembled inorganic gel with double network structures | 中国科学院兰州化学物理研究所 | 2021-11-19 | — | — | CN | claimed |
| CN-101528707-B | 2- [ 1-phenyl-5-hydroxy or methoxy-4 alpha-methyl-hexahydrocyclopenta [ f ] indazol-5-yl ] ethylphenyl derivatives useful as glucocorticoid receptor ligands | MERCK SHARP & DOHME | 2012-11-07 | — | — | CN | claimed |
| CN-101528707-A | 2- [ 1-phenyl-5-hydroxy or methoxy-4 alpha-methyl-hexahydrocyclopenta [ f ] indazol-5-yl ] ethylphenyl derivatives useful as glucocorticoid receptor ligands | MERCK & CO INC (US) | 2009-09-09 | — | — | CN | claimed |
| EP-1255728-B1 | INTEGRATED PROCESS FOR THE PREPARATION OF AROMATIC ISOCYANATES AND PROCEDURES FOR EFFECTING THE RELATIVE INTERMEDIATE PHASES | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-08-30 | — | — | EP | claimed |
| US-20030162995-A1 | Integrated process for the preparation of aromatic isocyanates and procedures for effecting the relative intermediate phases | DOW GLOBAL TECHNOLOGIES LLC | 2003-08-28 | — | — | US | claimed |
| CN-1419538-A | Integrated process for the preparation of aromatic isocyanates and procedures for effecting the relative intermediate phases | ENICHEM SPA (IT) | 2003-05-21 | — | — | CN | claimed |
| EP-1255728-A1 | INTEGRATED PROCESS FOR THE PREPARATION OF AROMATIC ISOCYANATES AND PROCEDURES FOR EFFECTING THE RELATIVE INTERMEDIATE PHASES | Enichem S.p.A. (IT) | 2002-11-13 | — | — | EP | claimed |
| WO-2001056977-A1 | INTEGRATED PROCESS FOR THE PREPARATION OF AROMATIC ISOCYANATES AND PROCEDURES FOR EFFECTING THE RELATIVE INTERMEDIATE PHASES | ENICHEM S.P.A. (IT) | 2001-08-09 | — | — | WO | claimed |
| US-5811402-A | ANTICOAGULANTS, THROMBIN INHIBITORS | ELI LILLY AND COMPANY (US) | 1998-09-22 | — | — | US | claimed |
| EP-0796866-A1 | Antithrombotic diamides | ELI LILLY AND COMPANY (US) | 1997-09-24 | — | — | EP | claimed |
| CN-1004353-B | Process for preparing N-methyl carbamates | 埃尼凯姆·辛泰希公司 | 1989-05-31 | — | — | CN | claimed |
| CN-85109417-A | The preparation method of N-methyl carbamate class | — | 1986-12-03 | — | — | CN | claimed |
| US-4384115-A | Process for preparing tetrahydro-1,3-oxazin-2-ones | THE DOW CHEMICAL COMPANY (US) | 1983-05-17 | — | — | US | claimed |
| US-11905361-B2 | Base proliferating agent, and base-reactive resin composition containing said base proliferating agent | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2024-02-20 | — | — | US | disclosed |
| CN-111918863-B | Heterocyclic compounds | 武田药品工业株式会社 | 2024-01-05 | — | — | CN | disclosed |
| CN-116323638-A | Stapled peptides and methods thereof | 弗格制药有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-0016346-A1 | Process for preparing urethanes | BAYER AG (DE) | 1980-10-01 | — | — | EP | disclosed |
| US-4122090-A | Cyclic esters of 3,4-dihydroxy-thiophene-1,1-dioxide compounds and 3,4-dihydroxy-cyclopentadienone compounds | BASF AKTIENGESELLSCHAFT (DE) | 1978-10-24 | — | — | US | disclosed |
| US-4100351-A | Method for preparing aromatic urethans | ANIC, S.P.A. (IT) | 1978-07-11 | — | — | US | disclosed |
| US-4100351-A | Method for preparing aromatic urethans | ANIC, S.P.A. (IT) | 1978-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11905361-B2 | Base proliferating agent, and base-reactive resin composition containing said base proliferating agent | PCNA, MKI67, POLR1A | PPID 3583/4885SMN1; SMN2 1393/4885TSHR 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.